Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Fossil Group, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results
-
Anika Reports Fourth Quarter and Year-End 2023 Financial Results
-
RCM Technologies, Inc. Announces Fourth Quarter and Fiscal Year 2023 Results
-
Ingredion Incorporated Declares Quarterly Dividend of $0.78 Per Share
-
NextNav Inc. Reports Fourth Quarter and Full Year 2023 Results
-
QuickLogic to Exhibit at GOMACTech 2024
-
Poseida Therapeutics Announces FDA Orphan Drug Designation Granted to P-BCMA-ALLO1 for the Treatment of Multiple Myeloma
-
Superior Group of Companies Reports Fourth Quarter Results
-
electroCore Announces Fourth Quarter and Full Year 2023 Financial Results
-
Vroom Announces Fourth Quarter and Full Year 2023 Results
-
KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance
-
Adams Resources & Energy, Inc. Announces Fourth Quarter And Full Year 2023 Results
-
Jamieson Wellness Inc. Reports Strong Fourth Quarter and Full Year 2023 Results
-
10x Genomics Begins Commercial Shipments of Chromium GEM-X Products
-
ESS Tech, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results
-
Purple Innovation to Present at the 36th Annual ROTH Conference
-
Pixie Dust Technologies Announces CFO Transition
-
Turtle Beach Announces Fourth Quarter and Full Year 2023 Earnings Results
-
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results
-
Generational Equity Advises Vanson Technology Services in its Sale to CORA Group
-
GrowGeneration Reports Fourth Quarter and Full Year 2023 Financial Results; Provides First Quarter and Full Year 2024 Guidance
-
Trevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024
-
California State Lottery Awards ICF New $58 Million Contract
-
Vivid Seats to Participate in Canaccord Genuity's eCommerce Sustainable Advantage Forum
-
PagerDuty Appoints Teresa Carlson to Board of Directors
-
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results
-
SuRo Capital Corp. Reports Fourth Quarter and Fiscal Year 2023 Financial Results
-
Fossil Group, Inc. Announces Leadership Changes
-
Culture Kings Returns as an Official Partner of Rolling Loud California
-
Vivid Seats to Participate in Canaccord Genuity's eCommerce Sustainable Advantage Forum
-
Acri Capital Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination
-
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024
-
PepGen to Participate in Upcoming Investor Conferences
-
Robinhood Markets, Inc. Reports February 2024 Operating Data
-
Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day
-
Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
-
H.B. Fuller to Report First Quarter 2024 Results on March 27, 2024
-
Invited Announces Commencement of Partial Tender Offer for its 8.50% Senior Notes due 2025
-
Anteriad Named A Strong Performer Among B2B Marketing and Sales Data Providers in Major Research Report
-
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
-
Mississippi Department of Education Partners with National Dropout Prevention Center to Implement Statewide Truancy Initiative
-
Tokyo Innovation Base: Tokyo's Node in the Global Startup Ecosystem, Opening May 2024
-
Outset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of Directors
-
Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2023 Financial Results on March 19, 2024
-
Cue Health Reports Fourth Quarter 2023 Financial Results
-
AGNC Investment Corp. Declares First Quarter Dividends on Preferred Stock
-
scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
-
AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for March 2024
-
Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH
-
Core Molding Technologies to Participate in the 36th Annual Roth Conference
